Cancer
DB-1311-O-1001
A Phase 1/2a, Multicenter, Open-Label, First-in-Human Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of DB-1311 in Subjects with Advanced/Metastatic Solid Tumors.
Trial overview
Clinical Area
Medical Oncology
Disease
Basket
Disease site
Basket
Study Phase
I
Trial Identifiers
Registration number: NCT05914116
Principal Investigator(s)
··
··